![Gary Titus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Titus
Directeur/Membre du Conseil chez
BioSight Ltd.
Profil
Gary S.
Titus is currently a Director at BioSight Ltd. He previously worked as a Senior Finance Director at IntraBiotics Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc. He was also the Chief Financial Officer & Senior Vice President at SciClone Pharmaceuticals LLC, Chief Financial & Accounting Officer, VP at Nuvelo, Inc., and Chief Financial Officer & Senior Vice President at Kosan Biosciences, Inc. He served as an Independent Director at ImmunoCellular Therapeutics Ltd. and was the Chief Financial Officer at BioCardia, Inc. and UroGen Pharma Ltd. He holds an undergraduate degree from the University of Florida and the University of South Florida.
Postes actifs de Gary Titus
| Sociétés | Poste | Début |
|---|---|---|
BioSight Ltd.
 BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Directeur/Membre du Conseil | - |
Anciens postes connus de Gary Titus
| Sociétés | Poste | Fin |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Directeur Financier/CFO | 05/07/2019 |
| UROGEN PHARMA LTD. | Directeur Financier/CFO | 05/06/2018 |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Directeur Financier/CFO | 01/01/2015 |
| SCICLONE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 31/05/2013 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Directeur Financier/CFO | 01/09/2008 |
Formation de Gary Titus
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
BioSight Ltd.
BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
